Medical Device Maker AngioDynamics Stock Jumps On Better Than Expected Q3 Earnings, Upbeat Annual Guidance

AngioDynamics Inc. (NASDAQ: ANGO) on Wednesday reported a third-quarter 2025 adjusted EPS of 3 cents, compared to the consensus for a per-share loss of 13 cents.

The maker of medical Instruments and supplies reported sales of $72 million, up 9.2% year over year, beating the consensus of $70.3 million.

Read Next: FDA Reviews Kidney Disease Drug From Apellis Pharmaceuticals

Med Tech’s net sales were $31.3 million, up 22.2%, driven by strength across all product lines, including Auryon sales of $13.9 million, up 17.3%, AngioVac sales of $6.8 million, up 23.1%, AlphaVac sales of $3 million, up 161.4%, and NanoKnife disposable sales of $4.9 million, which increased 16.2%.

Med Device net sales were $40.7 ...

https://www.benzinga.com/general/health-care/25/04/44608672/medical-device-maker-angiodynamics-stock-jumps-on-better-than-expected-q3-earnings-upbeat-ann